| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4137937
[patent_doc_number] => 06060272
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-09
[patent_title] => 'Human G-protein coupled receptors'
[patent_app_type] => 1
[patent_app_number] => 8/852824
[patent_app_country] => US
[patent_app_date] => 1997-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 4
[patent_no_of_words] => 20818
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/060/06060272.pdf
[firstpage_image] =>[orig_patent_app_number] => 852824
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/852824 | Human G-protein coupled receptors | May 6, 1997 | Issued |
| 08/852218 | EOSINOPHIL DEPLETION; COMPOSTIONS; METHODS | May 6, 1997 | Abandoned |
Array
(
[id] => 3887419
[patent_doc_number] => 05834242
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-10
[patent_title] => 'Human clathrin-associated protein'
[patent_app_type] => 1
[patent_app_number] => 8/850119
[patent_app_country] => US
[patent_app_date] => 1997-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17727
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/834/05834242.pdf
[firstpage_image] =>[orig_patent_app_number] => 850119
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/850119 | Human clathrin-associated protein | Apr 30, 1997 | Issued |
| 08/846523 | HUMAN C-TYPE LECTIN | Apr 28, 1997 | Abandoned |
Array
(
[id] => 3947468
[patent_doc_number] => 05955305
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Human retinoid binding protein'
[patent_app_type] => 1
[patent_app_number] => 8/847724
[patent_app_country] => US
[patent_app_date] => 1997-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19958
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955305.pdf
[firstpage_image] =>[orig_patent_app_number] => 847724
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/847724 | Human retinoid binding protein | Apr 27, 1997 | Issued |
Array
(
[id] => 4236538
[patent_doc_number] => 06117977
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-12
[patent_title] => 'Type C lectins'
[patent_app_type] => 1
[patent_app_number] => 8/840062
[patent_app_country] => US
[patent_app_date] => 1997-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 19
[patent_no_of_words] => 34082
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 491
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/117/06117977.pdf
[firstpage_image] =>[orig_patent_app_number] => 840062
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/840062 | Type C lectins | Apr 23, 1997 | Issued |
| 08/844359 | BIFUNCTIONAL POLYPEPTIDES FOR CELL-SPECIFIC VIRAL TARGETING | Apr 17, 1997 | Abandoned |
| 08/839449 | METHOD OF IDENTIFYING MODULATORS OF CELL SURFACE MEMBRANE RECEPTORS USEFUL IN THE TREATMENT OF DISEASE | Apr 13, 1997 | Abandoned |
| 08/832340 | WNT RECEPTOR COMPOSITIONS AND METHODS | Apr 10, 1997 | Abandoned |
Array
(
[id] => 4200839
[patent_doc_number] => 06013769
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-11
[patent_title] => 'X-linked adrenoleukodystrophy gene and corresponding protein'
[patent_app_type] => 1
[patent_app_number] => 8/835734
[patent_app_country] => US
[patent_app_date] => 1997-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 7
[patent_no_of_words] => 11403
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/013/06013769.pdf
[firstpage_image] =>[orig_patent_app_number] => 835734
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/835734 | X-linked adrenoleukodystrophy gene and corresponding protein | Apr 9, 1997 | Issued |
Array
(
[id] => 3947422
[patent_doc_number] => 05955303
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Human chemokine receptor-like protein'
[patent_app_type] => 1
[patent_app_number] => 8/812871
[patent_app_country] => US
[patent_app_date] => 1997-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 3
[patent_no_of_words] => 18018
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955303.pdf
[firstpage_image] =>[orig_patent_app_number] => 812871
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/812871 | Human chemokine receptor-like protein | Mar 5, 1997 | Issued |
Array
(
[id] => 3980269
[patent_doc_number] => 05891076
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-04-06
[patent_title] => 'Hypertrophic scar dressing'
[patent_app_type] => 1
[patent_app_number] => 8/793823
[patent_app_country] => US
[patent_app_date] => 1997-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 3475
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/891/05891076.pdf
[firstpage_image] =>[orig_patent_app_number] => 793823
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/793823 | Hypertrophic scar dressing | Mar 3, 1997 | Issued |
Array
(
[id] => 3767003
[patent_doc_number] => 05849502
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Annexin containing compositions and methods for their use'
[patent_app_type] => 1
[patent_app_number] => 8/794941
[patent_app_country] => US
[patent_app_date] => 1997-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5996
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849502.pdf
[firstpage_image] =>[orig_patent_app_number] => 794941
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/794941 | Annexin containing compositions and methods for their use | Feb 3, 1997 | Issued |
Array
(
[id] => 3760592
[patent_doc_number] => 05843885
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-01
[patent_title] => 'ICAM-1/LFA-1 short-chain peptides and method of using same'
[patent_app_type] => 1
[patent_app_number] => 8/789078
[patent_app_country] => US
[patent_app_date] => 1997-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 8706
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/843/05843885.pdf
[firstpage_image] =>[orig_patent_app_number] => 789078
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/789078 | ICAM-1/LFA-1 short-chain peptides and method of using same | Feb 2, 1997 | Issued |
Array
(
[id] => 3985119
[patent_doc_number] => 05861484
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-19
[patent_title] => 'Inhibitor of vascular endothelial cell growth factor'
[patent_app_type] => 1
[patent_app_number] => 8/786164
[patent_app_country] => US
[patent_app_date] => 1997-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 24
[patent_no_of_words] => 9718
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/861/05861484.pdf
[firstpage_image] =>[orig_patent_app_number] => 786164
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/786164 | Inhibitor of vascular endothelial cell growth factor | Jan 20, 1997 | Issued |
Array
(
[id] => 3941742
[patent_doc_number] => 05976814
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 8/495695
[patent_app_country] => US
[patent_app_date] => 1997-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 9
[patent_no_of_words] => 28952
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/976/05976814.pdf
[firstpage_image] =>[orig_patent_app_number] => 495695
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/495695 | DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof | Jan 12, 1997 | Issued |
Array
(
[id] => 4310403
[patent_doc_number] => 06236946
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-22
[patent_title] => 'Nuclear receptor ligands and ligand binding domains'
[patent_app_type] => 1
[patent_app_number] => 8/764870
[patent_app_country] => US
[patent_app_date] => 1996-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 229
[patent_figures_cnt] => 231
[patent_no_of_words] => 26137
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/236/06236946.pdf
[firstpage_image] =>[orig_patent_app_number] => 764870
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/764870 | Nuclear receptor ligands and ligand binding domains | Dec 12, 1996 | Issued |
Array
(
[id] => 3945511
[patent_doc_number] => 05878373
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-03-02
[patent_title] => 'System and method for determining three-dimensional structure of protein sequences'
[patent_app_type] => 1
[patent_app_number] => 8/761724
[patent_app_country] => US
[patent_app_date] => 1996-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 9056
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/878/05878373.pdf
[firstpage_image] =>[orig_patent_app_number] => 761724
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/761724 | System and method for determining three-dimensional structure of protein sequences | Dec 5, 1996 | Issued |
Array
(
[id] => 4000376
[patent_doc_number] => 05862514
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-19
[patent_title] => 'Method and means for synthesis-based simulation of chemicals having biological functions'
[patent_app_type] => 1
[patent_app_number] => 8/758741
[patent_app_country] => US
[patent_app_date] => 1996-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 5483
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 188
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/862/05862514.pdf
[firstpage_image] =>[orig_patent_app_number] => 758741
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/758741 | Method and means for synthesis-based simulation of chemicals having biological functions | Dec 5, 1996 | Issued |
Array
(
[id] => 3931706
[patent_doc_number] => 05939284
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-17
[patent_title] => 'Protein phosphatase 1 binding protein, R5'
[patent_app_type] => 1
[patent_app_number] => 8/767096
[patent_app_country] => US
[patent_app_date] => 1996-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 24829
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/939/05939284.pdf
[firstpage_image] =>[orig_patent_app_number] => 767096
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/767096 | Protein phosphatase 1 binding protein, R5 | Dec 4, 1996 | Issued |